6H-Dibenzo[b,d]pyran-1-ol,6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)- cas no:5957-75-5

Name6H-Dibenzo[b,d]pyran-1-ol,6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-
CAS5957-75-5
Synonyms6H-Dibenzo[b,d]pyran-1-ol,6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-;6H-Dibenzo[b,d]pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-,trans-(-)- (8CI); (-)-trans-D8-Tetrahydrocannabinol; (-)-D6-Tetrahydrocannabinol; (-)-D8-6a,10a-trans-Tetrahydrocannabinol; (-)-D8-THC; (-)-D8-Tetrahydrocannabinol; (-)-D8-trans-Tetrahydrocannabinol;Cannabinol, D1(6)-tetrahydro-;NSC 134453; l-D8-Tetrahydrocannabinol;trans-D8-Tetrahydrocannabinol; D1(6)-Tetrahydrocannabinol; D1(6)-trans-Tetrahydrocannabinol; D6-Tetrahydrocannabinol; D8-THC; D8-Tetrahydrocannabinol; D8-l-Tetrahydrocannabinol; D8-trans-Tetrahydrocannabinol
Molecular FormulaC21H30 O2
Molecular Weight314.51

refractive index1.528
storage temp−20°C

Hazard F: Flammable;
Risk 11-39/23/24/25-23/24/25
Safety

Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion. Human mutation data reported. An hallucinatory drug. When heated to decomposition it emits acrid smoke and irritating fumes. See also CANNABIS.Safety information of Tetrahydrocannabinols (-)-delta6-3,4-trans-form (5957-75-5):
Hazard Codes  F
Risk Statements 
11  Highly Flammable
39/23/24/25  Toxic: danger of very serious irreversible effects through inhalation, in contact with skin and if swallowed
Safety Statements 
7  Keep container tightly closed
16  Keep away from sources of ignition - No smoking
36/37  Wear suitable protective clothing and gloves
45  In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
RIDADR  UN 1170 3/PG 2

1.		dni-hmn:hla 10 µmol/L		ANTRD4    Anticancer Research. 3 (1983),211.
2.		oms-mus-ipr 200 mg/kg		RCOCB8    Research Communications in Chemical Pathology and Pharmacology. 17 (1977),703.
3.		orl-rat LD50:860 mg/kg		TXAPA9    Toxicology and Applied Pharmacology. 25 (1973),363.
4.		ipr-rat LD50:560 mg/kg		AIPTAK    Archives Internationales de Pharmacodynamie et de Therapie. 196 (1972),133.
5.		ivn-rat LD50:97 mg/kg		AIPTAK    Archives Internationales de Pharmacodynamie et de Therapie. 196 (1972),133.
6.		ipr-mus LD50:210 mg/kg		AIPTAK    Archives Internationales de Pharmacodynamie et de Therapie. 196 (1972),133.
7.		ivn-mus LD50:27,500 µg/kg		JMCMAR    Journal of Medicinal Chemistry. 21 (1978),1079.